Hesselink Thomas L MD is categorized under Physicians Offices in Bolingbrook, IL and active since 1994.
Hesselink Thomas L MD was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas Hesselink at the company’s single location by writing to 391 Quadrangle Drive # S1, Bolingbrook, Illinois IL 60440 or by phoning (630) 844-0011. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hesselink Thomas L MD |
| Contact Person: | Thomas Hesselink |
| Address: | 391 Quadrangle Drive # S1, Bolingbrook, Illinois 60440 |
| Phone Number: | (630) 844-0011 |
| Website Address: | bioredox.mysite.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Hesselink Thomas L MD was started in 1994 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas Hesselink for inquiries that concern Hesselink Thomas L MD by calling the company number (630) 844-0011, as your correspondence is most welcome. Additionally, the physical location of the single location of Hesselink Thomas L MD can be found at the coordinates 41.68891,-88.07539 as well as the street address 391 Quadrangle Drive # S1 in Bolingbrook, Illinois 60440.
For its online presence, you may visit Hesselink Thomas L MD’s website at bioredox.mysite.com and engage with its social media outlets through on Twitter and on Facebook.